1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. CYCLO THERAPEUTICS INC - ORDINARY SHARES - CLASS A
Cyclo Therapeutics Inc - Ordinary Shares - Class A XNAS: CYTH

Cyclo Therapeutics Inc - Ordinary Shares - Class A - CYTH - stock price prediction, stock price target, analyst ratings from 3 analysts

Cyclo Therapeutics Inc - Ordinary Shares - Class A has a share price target of US$ 1, revenue growth forecast of -10.2%, and profit growth estimate of -12.0% for FY24, based on top 3 analyst calls.